- Home
- Publications
- Publication Search
- Publication Details
Title
Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-08-09
DOI
10.3389/fimmu.2019.01862
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment Effects of the Second-Generation Tyrosine Kinase Inhibitor Dasatinib on Autoimmune Arthritis
- (2019) Kai Guo et al. Frontiers in Immunology
- Psoriasis Pathogenesis and Treatment
- (2019) Adriana Rendon et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Fostamatinib for the treatment of chronic immune thrombocytopenia
- (2019) Nathan T. Connell et al. BLOOD
- Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases
- (2019) Anniina T. Virtanen et al. BIODRUGS
- Disease course and treatment effects of a JAK inhibitor in a patient with CANDLE syndrome
- (2019) M. Boyadzhiev et al. Pediatric Rheumatology
- Role of Src and Cortactin in Pemphigus Skin Blistering
- (2019) Daniela Kugelmann et al. Frontiers in Immunology
- Mechanisms of Inflammation in Neutrophil-Mediated Skin Diseases
- (2019) Angelo V. Marzano et al. Frontiers in Immunology
- Targeting interferons and their pathways in systemic lupus erythematosus
- (2018) François Chasset et al. AUTOIMMUNITY REVIEWS
- Tofacitinib in patients with moderate to severe chronic plaque psoriasis: long-term safety and efficacy in an open-label extension study
- (2018) F. Valenzuela et al. BRITISH JOURNAL OF DERMATOLOGY
- Efficacy and safety of the Janus kinase 1 inhibitor PF-04965842 in patients with moderate-to-severe psoriasis: phase II, randomized, double-blind, placebo-controlled study
- (2018) G.J. Schmieder et al. BRITISH JOURNAL OF DERMATOLOGY
- Thromboembolism with Janus Kinase (JAK) Inhibitors for Rheumatoid Arthritis: How Real is the Risk?
- (2018) Ian C. Scott et al. DRUG SAFETY
- Translational and clinical advances in JAK-STAT biology: The present and future of jakinibs
- (2018) Massimo Gadina et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients
- (2018) Lucy Y. Liu et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial
- (2018) Daniel J Wallace et al. LANCET
- Pathogenesis of Skin Injury of Systemic Lupus Erythematosus
- (2018) Guo-Min Deng Current Rheumatology Reports
- Whole-Genome Expression Profiling in Skin Reveals SYK As a Key Regulator of Inflammation in Experimental Epidermolysis Bullosa Acquisita
- (2018) Unni K. Samavedam et al. Frontiers in Immunology
- Lineage-Specific Analysis of Syk Function in Autoantibody-Induced Arthritis
- (2018) Tamás Németh et al. Frontiers in Immunology
- Pemphigus—A Disease of Desmosome Dysfunction Caused by Multiple Mechanisms
- (2018) Volker Spindler et al. Frontiers in Immunology
- Atopic dermatitis
- (2018) Stephan Weidinger et al. Nature Reviews Disease Primers
- Benefit-risk of tofacitinib in patients with moderate to severe chronic plaque psoriasis: Pooled analysis across 6 clinical trials
- (2018) B.E. Strober et al. BRITISH JOURNAL OF DERMATOLOGY
- Tofacitinib as the potent treatment for refractory pemphigus: A possible alternative treatment for pemphigus
- (2018) Soheil Tavakolpour Dermatologic Therapy
- Cutting Edge: Dysregulated CARD9 Signaling in Neutrophils Drives Inflammation in a Mouse Model of Neutrophilic Dermatoses
- (2018) Sarang Tartey et al. JOURNAL OF IMMUNOLOGY
- Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis
- (2018) Kim Papp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dupilumab for the Treatment of Recalcitrant Bullous Pemphigoid
- (2018) Alex Kaye et al. JAMA Dermatology
- Genomic alterations driving psoriasis pathogenesis
- (2018) S. Singh et al. GENE
- Topical Application of JAK1/JAK2 Inhibitor Momelotinib Exhibits Significant Anti-Inflammatory Responses in DNCB-Induced Atopic Dermatitis Model Mice
- (2018) Wenyu Jin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis
- (2018) Teruki Dainichi et al. NATURE IMMUNOLOGY
- CD11b-deficient mice exhibit an increased severity in the late phase of antibody transfer-induced experimental epidermolysis bullosa acquisita
- (2017) Fengyuan Deng et al. EXPERIMENTAL DERMATOLOGY
- A novel JAK inhibitor JTE-052 reduces skin inflammation and ameliorates chronic dermatitis in rodent models: Comparison with conventional therapeutic agents
- (2017) Atsuo Tanimoto et al. EXPERIMENTAL DERMATOLOGY
- Tyrosine Kinase SYK Licenses MyD88 Adaptor Protein to Instigate IL-1α-Mediated Inflammatory Disease
- (2017) Prajwal Gurung et al. IMMUNITY
- P67: LONG-TERM MANAGEMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS WITH DUPILUMAB AND CONCOMITANT TOPICAL CORTICOSTEROIDS: A 1-YEAR RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL (CHRONOS)
- (2017) A Blauvelt et al. INTERNAL MEDICINE JOURNAL
- γδTCR recruits the Syk/PI3K axis to drive proinflammatory differentiation program
- (2017) Ryunosuke Muro et al. JOURNAL OF CLINICAL INVESTIGATION
- Effect of tofacitinib on lipid levels and lipid-related parameters in patients with moderate to severe psoriasis
- (2017) Robert Wolk et al. Journal of Clinical Lipidology
- The efficacy and safety of tofacitinib in Asian patients with moderate to severe chronic plaque psoriasis: A Phase 3, randomized, double-blind, placebo-controlled study
- (2017) JianZhong Zhang et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Syk inhibitors in clinical development for hematological malignancies
- (2017) Delong Liu et al. Journal of Hematology & Oncology
- The Syk Tyrosine Kinase Is Required for Skin Inflammation in an In Vivo Mouse Model of Epidermolysis Bullosa Acquisita
- (2017) Tamás Németh et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure
- (2017) Lucy Y. Liu et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib
- (2017) Brooke Rothstein et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Expression of the JAK/STAT Signaling Pathway in Bullous Pemphigoid and Dermatitis Herpetiformis
- (2017) K. Juczynska et al. MEDIATORS OF INFLAMMATION
- JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
- (2017) Daniella M. Schwartz et al. NATURE REVIEWS DRUG DISCOVERY
- Discovery of TAK-659 an orally available investigational inhibitor of Spleen Tyrosine Kinase (SYK)
- (2016) Betty Lam et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Are neutrophilic dermatoses autoinflammatory disorders?
- (2016) T.K. Satoh et al. BRITISH JOURNAL OF DERMATOLOGY
- Investigation of selective JAK1 inhibitor GSK2586184 for the treatment of psoriasis in a randomized placebo-controlled phase IIa study
- (2016) V.J. Ludbrook et al. BRITISH JOURNAL OF DERMATOLOGY
- A randomized phase 2b trial of baricitinib, an oral Janus kinase (JAK) 1/JAK2 inhibitor, in patients with moderate-to-severe psoriasis
- (2016) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial
- (2016) R. Bissonnette et al. BRITISH JOURNAL OF DERMATOLOGY
- The tyrosine kinase inhibitor dasatinib reduces lung inflammation and remodelling in experimental allergic asthma
- (2016) AL da Silva et al. BRITISH JOURNAL OF PHARMACOLOGY
- Janus kinase inhibitors for rheumatoid arthritis
- (2016) Kunihiro Yamaoka CURRENT OPINION IN CHEMICAL BIOLOGY
- Interleukin 4 inhibition as a potential therapeutic in pemphigus
- (2016) Soheil Tavakolpour et al. CYTOKINE
- Tyrosine kinase signaling pathways in neutrophils
- (2016) Krisztina Futosi et al. IMMUNOLOGICAL REVIEWS
- Tofacitinib attenuates pathologic immune pathways in patients with psoriasis: A randomized phase 2 study
- (2016) James Krueger et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Hyperactivation of JAK1 tyrosine kinase induces stepwise, progressive pruritic dermatitis
- (2016) Takuwa Yasuda et al. JOURNAL OF CLINICAL INVESTIGATION
- PRT062607 Achieves Complete Inhibition of the Spleen Tyrosine Kinase at Tolerated Exposures Following Oral Dosing in Healthy Volunteers
- (2016) Greg Coffey et al. JOURNAL OF CLINICAL PHARMACOLOGY
- JAK inhibitor JTE-052 regulates contact hypersensitivity by downmodulating T cell activation and differentiation
- (2016) Wataru Amano et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- A randomized, double-blind, placebo-controlled, dose-escalation study of the safety and efficacy of INCB039110, an oral janus kinase 1 inhibitor, in patients with stable, chronic plaque psoriasis
- (2016) Robert Bissonnette et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Oral tofacitinib efficacy, safety and tolerability in Japanese patients with moderate to severe plaque psoriasis and psoriatic arthritis: A randomized, double-blind, phase 3 study
- (2016) Akihiko Asahina et al. JOURNAL OF DERMATOLOGY
- Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study
- (2016) Kim A. Papp et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Neutrophil-specific deletion of the CARD9 gene expression regulator suppresses autoantibody-induced inflammation in vivo
- (2016) Tamás Németh et al. Nature Communications
- Identification of a Functional Risk Variant for Pemphigus Vulgaris in the ST18 Gene
- (2016) Dan Vodo et al. PLoS Genetics
- Psoriasis
- (2016) Jacqueline E. Greb et al. Nature Reviews Disease Primers
- An open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemia
- (2015) J. Sharman et al. BLOOD
- Tofacitinib withdrawal and retreatment in moderate-to-severe chronic plaque psoriasis: a randomized controlled trial
- (2015) R. Bissonnette et al. BRITISH JOURNAL OF DERMATOLOGY
- Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials
- (2015) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- The role of cytokines in the pathogenesis of cutaneous lupus erythematosus
- (2015) E.S. Robinson et al. CYTOKINE
- Conditional depletion of mast cells has no impact on the severity of experimental epidermolysis bullosa acquisita
- (2015) Anika Kasprick et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Therapeutic effects of dasatinib in mouse model of multiple sclerosis
- (2015) Gholamreza Azizi et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling
- (2015) Wataru Amano et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Ruxolitinib Attenuates Cutaneous Lupus Development in a Mouse Lupus Model
- (2015) Emilie S. Chan et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Angiogenesis and lymphangiogenesis in inflammatory skin disorders
- (2015) Gilda Varricchi et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial
- (2015) Hervé Bachelez et al. LANCET
- Pathogenesis and targeted treatment of skin injury in SLE
- (2015) Guo-Min Deng et al. Nature Reviews Rheumatology
- Tofacitinib Citrate for the Treatment of Vitiligo
- (2015) Brittany G. Craiglow et al. JAMA Dermatology
- Pharmacologic inhibition of JAK-STAT signaling promotes hair growth
- (2015) S. Harel et al. Science Advances
- Fcγ Receptors III and IV Mediate Tissue Destruction in a Novel Adult Mouse Model of Bullous Pemphigoid
- (2014) Franziska S. Schulze et al. AMERICAN JOURNAL OF PATHOLOGY
- What is the future of targeted therapy in rheumatology: biologics or small molecules?
- (2014) Attila Mócsai et al. BMC Medicine
- Advances in kinase inhibition
- (2014) Massimo Gadina CURRENT OPINION IN RHEUMATOLOGY
- The Src family kinases Hck, Fgr, and Lyn are critical for the generation of the in vivo inflammatory environment without a direct role in leukocyte recruitment
- (2014) Miklós Kovács et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Bullous Pemphigoid Autoantibodies Directly Induce Blister Formation without Complement Activation
- (2014) Hideyuki Ujiie et al. JOURNAL OF IMMUNOLOGY
- Inhibition of TYK2 and JAK1 Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis by Inhibiting IL-22 and the IL-23/IL-17 Axis
- (2014) Melissa G. Works et al. JOURNAL OF IMMUNOLOGY
- Discovery of GS-9973, a Selective and Orally Efficacious Inhibitor of Spleen Tyrosine Kinase
- (2014) Kevin S. Currie et al. JOURNAL OF MEDICINAL CHEMISTRY
- Omalizumab therapy for bullous pemphigoid
- (2014) Kenneth K. Yu et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- (2014) Luzhou Xing et al. NATURE MEDICINE
- Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
- (2014) Lisa A. Beck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interferon-γ Induces Senescence in Normal Human Melanocytes
- (2014) Suiquan Wang et al. PLoS One
- CXCL10 Is Critical for the Progression and Maintenance of Depigmentation in a Mouse Model of Vitiligo
- (2014) M. Rashighi et al. Science Translational Medicine
- Bullous Pemphigoid IgG Induces BP180 Internalization via a Macropinocytic Pathway
- (2013) Sho Hiroyasu et al. AMERICAN JOURNAL OF PATHOLOGY
- The Epithelial Cell-Derived Atopic Dermatitis Cytokine TSLP Activates Neurons to Induce Itch
- (2013) Sarah R. Wilson et al. CELL
- Tyrosine Kinase Inhibitors for the Treatment of Rheumatoid Arthritis
- (2013) Jose A. Gomez-Puerta et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Differential selectivity of JAK2 inhibitors in enzymatic and cellular settings
- (2013) Violeta Yu et al. EXPERIMENTAL HEMATOLOGY
- Tyk2 is a therapeutic target for psoriasis-like skin inflammation
- (2013) M. Ishizaki et al. INTERNATIONAL IMMUNOLOGY
- Immunologic and genetic considerations of cutaneous lupus erythematosus: A comprehensive review
- (2013) Cong Yu et al. JOURNAL OF AUTOIMMUNITY
- B Cell-Specific Loss of Lyn Kinase Leads to Autoimmunity
- (2013) C. Lamagna et al. JOURNAL OF IMMUNOLOGY
- The ErbB/HER family of protein-tyrosine kinases and cancer
- (2013) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Epidermal EGFR Controls Cutaneous Host Defense and Prevents Inflammation
- (2013) B. M. Lichtenberger et al. Science Translational Medicine
- Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapy
- (2013) Cheng Liao et al. ARTHRITIS RESEARCH & THERAPY
- Development of a Highly Selective c-Src Kinase Inhibitor
- (2012) Kristoffer R. Brandvold et al. ACS Chemical Biology
- JAK inhibition with tofacitinib suppresses arthritic joint structural damage through decreased RANKL production
- (2012) Timothy P. LaBranche et al. ARTHRITIS AND RHEUMATISM
- Regulation of inflammatory responses in tumor necrosis factor-activated and rheumatoid arthritis synovial macrophages by JAK inhibitors
- (2012) Anna Yarilina et al. ARTHRITIS AND RHEUMATISM
- Dasatinib inhibits proinflammatory functions of mature human neutrophils
- (2012) K. Futosi et al. BLOOD
- Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice
- (2012) L. P. Kil et al. BLOOD
- Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study
- (2012) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- IL-4 up-regulates epidermal chemotactic, angiogenic, and pro-inflammatory genes and down-regulates antimicrobial genes in vivo and in vitro: Relevant in the pathogenesis of atopic dermatitis
- (2012) Lei Bao et al. CYTOKINE
- Inhibition of FAK prevents blister formation in the neonatal mouse model of pemphigus vulgaris
- (2012) María P. Gil et al. EXPERIMENTAL DERMATOLOGY
- Tec Family Kinases in Inflammation and Disease
- (2012) Nicole J. Horwood et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- TSLP Produced by Keratinocytes Promotes Allergen Sensitization through Skin and Thereby Triggers Atopic March in Mice
- (2012) Juan Manuel Leyva-Castillo et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Preliminary clinical activity of a topical JAK1/2 inhibitor in the treatment of psoriasis
- (2012) Naresh Punwani et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Pemphigoid diseases
- (2012) Enno Schmidt et al. LANCET
- IL-4 regulates chemokine CCL26 in keratinocytes through the Jak1, 2/Stat6 signal transduction pathway: Implication for atopic dermatitis
- (2012) Lei Bao et al. MOLECULAR IMMUNOLOGY
- An important role of lymphatic vessel activation in limiting acute inflammation
- (2011) R. Huggenberger et al. BLOOD
- Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin Inflammation
- (2011) Yihua Cai et al. IMMUNITY
- The C5a Receptor on Mast Cells Is Critical for the Autoimmune Skin-blistering Disease Bullous Pemphigoid
- (2011) Lisa Heimbach et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Deletion of Syk in Neutrophils Prevents Immune Complex Arthritis
- (2011) Emily R. Elliott et al. JOURNAL OF IMMUNOLOGY
- Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)
- (2011) Kamran Ghoreschi et al. JOURNAL OF IMMUNOLOGY
- Preclinical Evaluation of Local JAK1 and JAK2 Inhibition in Cutaneous Inflammation
- (2011) Jordan S. Fridman et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Genetic deficiency of Syk protects mice from autoantibody-induced arthritis
- (2010) Zoltán Jakus et al. ARTHRITIS AND RHEUMATISM
- Inhibition of spleen tyrosine kinase suppresses skin and kidney disease in lupus prone mice
- (2010) Guo-Min Deng et al. ARTHRITIS AND RHEUMATISM
- Signal transduction by the atopy-associated human thymic stromal lymphopoietin (TSLP) receptor depends on Janus kinase function
- (2010) Andreas Wohlmann et al. BIOLOGICAL CHEMISTRY
- PRT-060318, a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model
- (2010) M. P. Reilly et al. BLOOD
- Neutrophil development and function critically depend on Bruton tyrosine kinase in a mouse model of X-linked agammaglobulinemia
- (2010) K. Fiedler et al. BLOOD
- Cell Signaling by Receptor Tyrosine Kinases
- (2010) Mark A. Lemmon et al. CELL
- Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation
- (2010) Reto Huggenberger et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Human IgG1 Monoclonal Antibody against Human Collagen 17 Noncollagenous 16A Domain Induces Blisters via Complement Activation in Experimental Bullous Pemphigoid Model
- (2010) Q. Li et al. JOURNAL OF IMMUNOLOGY
- Involvement of TH1/TH2 Cytokines in the Pathogenesis of Autoimmune Skin Disease—Pemphigus Vulgaris
- (2009) Abhigyan Satyam et al. IMMUNOLOGICAL INVESTIGATIONS
- IgG from Patients with Bullous Pemphigoid Depletes Cultured Keratinocytes of the 180-kDa Bullous Pemphigoid Antigen (Type XVII Collagen) and Weakens Cell Attachment
- (2009) Hiroaki Iwata et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis
- (2009) Antonella Di Cesare et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence
- (2009) Olaf Gross et al. NATURE
- Inhibition of Chronic and Acute Skin Inflammation by Treatment with a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor
- (2008) Cornelia Halin et al. AMERICAN JOURNAL OF PATHOLOGY
- Treatment of rheumatoid arthritis with a syk kinase inhibitor: A twelve-week, randomized, placebo-controlled trial
- (2008) Michael E. Weinblatt et al. ARTHRITIS AND RHEUMATISM
- Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model
- (2008) Zhi Liu et al. JOURNAL OF AUTOIMMUNITY
- Disruption of Desmosome Assembly by Monovalent Human Pemphigus Vulgaris Monoclonal Antibodies
- (2008) Xuming Mao et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Animal Models of Atopic Dermatitis
- (2008) Haoli Jin et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Cartilage preservation by inhibition of Janus kinase 3 in two rodent models of rheumatoid arthritis
- (2008) Anthony J Milici et al. ARTHRITIS RESEARCH & THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More